At a glance
ClinicalIndex Comparison RecordN/ACompleted· 322 enrolled
Drug / intervention
Decision Support Tool with Active Monitoring +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Mathematics of Breast Cancer Overtreatment: Improving Treatment Choice Through Effective Communication of Personalized Cancer Risk
In Brief
A clinical study evaluating Decision Support Tool with Active Monitoring and Decision Support Tool without Active Monitoring for Ductal Carcinoma in Situ. Completed, enrolled 322 participants across 1 site.
Detailed Summary
The purpose of this research study is to evaluate a decision support tool for patients diagnosed with ductal carcinoma in situ (DCIS).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDuctal Carcinoma in Situ
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 2018
Enrollment StartOct 2021
Primary CompletionJan 2022
TodayJul 2026
First PostedDec 13, 2018
Enrollment StartOct 12, 2021
Primary CompletionJan 31, 2022
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 7.6 years ago
Interventions
Decision Support Tool with Active Monitoringbehavioral
The decision support tool communicates trade-offs for different management strategies for DCIS, including active monitoring and surgery options.
Decision Support Tool without Active Monitoringbehavioral
The decision support tool communicates trade-offs for different management strategies for DCIS, including surgery options only.